Literature DB >> 4329327

A seroepidemiologic study of adenovirus-associated virus infection in infants and children.

N R Blacklow, M D Hoggan, M S Sereno, C D Brandt, H W Kim, R H Parrott, R M Chanock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4329327     DOI： 10.1093/oxfordjournals.aje.a121331

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  37 in total

1.  Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.

Authors:  Shaoyong Li; Chen Ling; Li Zhong; Mengxin Li; Qin Su; Ran He; Qiushi Tang; Dale L Greiner; Leonard D Shultz; Michael A Brehm; Terence R Flotte; Christian Mueller; Arun Srivastava; Guangping Gao
Journal:  Mol Ther       Date:  2015-09-25       Impact factor: 11.454

2.  Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?

Authors:  Kenneth I Berns; Barry J Byrne; Terence R Flotte; Guangping Gao; William W Hauswirth; Roland W Herzog; Nicholas Muzyczka; Thierry VandenDriessche; Xiao Xiao; Sergei Zolotukhin; Arun Srivastava
Journal:  Hum Gene Ther       Date:  2015-12       Impact factor: 5.695

3.  Adeno-associated virus in adenovirus type 3 conjunctivitis.

Authors:  O W Schmidt; M K Cooney; H M Foy
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

Review 4.  Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.

Authors:  Pedro R Lowenstein; Ronald J Mandel; Wei-Dong Xiong; Kurt Kroeger; Maria G Castro
Journal:  Curr Gene Ther       Date:  2007-10       Impact factor: 4.391

5.  Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.

Authors:  Brittney L Gurda; Christina Raupp; Ruth Popa-Wagner; Matthias Naumer; Norman H Olson; Robert Ng; Robert McKenna; Timothy S Baker; Jürgen A Kleinschmidt; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

6.  Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors.

Authors:  D D Koeberl; I E Alexander; C L Halbert; D W Russell; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

7.  Host and vector-dependent effects on the risk of germline transmission of AAV vectors.

Authors:  Patricia Favaro; Harre D Downey; J Shangzhen Zhou; J Fraser Wright; Bernd Hauck; Federico Mingozzi; Katherine A High; Valder R Arruda
Journal:  Mol Ther       Date:  2009-03-17       Impact factor: 11.454

Review 8.  Large animal models of neurological disorders for gene therapy.

Authors:  Christine Gagliardi; Bruce A Bunnell
Journal:  ILAR J       Date:  2009

9.  Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain.

Authors:  Eleni A Markakis; Kenneth P Vives; Jeremy Bober; Stefan Leichtle; Csaba Leranth; Jeff Beecham; John D Elsworth; Robert H Roth; R Jude Samulski; D Eugene Redmond
Journal:  Mol Ther       Date:  2009-12-15       Impact factor: 11.454

10.  Acquisition of selective antitumoral effects of recombinant adeno-associated virus by genetically inserting tumor-targeting peptides into capsid proteins.

Authors:  Han Saem Lee; Ji Yun Kim; Won Il Lee; Sung Jin Kim; Min Ji Ko; Sunjoo Jeong; Keerang Park; Han Choe; Heuiran Lee
Journal:  Oncol Lett       Date:  2011-08-08       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.